RF49
GOODGSK Capital B.V. Publishes 2024 Annual Report
The major retailer has published its 2024 annual report, providing investors with a comprehensive overview of the company's financial performance and operational activities over the past year.
RF49
0.00%
Market Cap
Volume
0
NaN% of avg
P/E Ratio
N/A
EPS (TTM)
N/A
Beta
N/A
Day Range
p - p
52 Week Range
N/AppN/Ap
p
Upcoming Events
27 June 2026
Publication of 2025 Annual Report and Financial Statements
No data available for this timeframe
RF49
NEUTRALGSK Capital B.V. Publishes Annual Report
Pharmaceutical company GSK Capital B.V. publishes its annual report for 2023.
You're all caught up!